How Tirzepatide Works: Dual Agonist Mechanism Tirzepatide is a dual GIP/GLP-1 receptor agonist that functions as a single synthetic peptide with affinity for both receptors
They evaluated structured endpoints over many weeks
Beautiful charts can help you understand how you might feel on day two versus day six, helping you plan workouts, meals and social events accordingly
Kalpna Singh Shekhawat, BSN, RN, NP About the author Iraphan Khan, BSN, RN, D.Pharm, is the founder of RealMedVision and a Public Health Researcher who creates evidence-based health content from trusted medical sources
We included patients who had been treated with an SGLT2i or GLP-1 RA for at least 6 months and analysed the efficacy, safety and cardio-renal outcomes 5 years after initiation of therapy
If you still have questions about how to use them after reading this article, talk to your doctor or pharmacist.